UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
PayPal
PYPL
$47.4B
| $473M | 0.1% |
7,047,709
-2,210,212
| -24% | -$156M |
2015 Q3
40 quarters
|
|
177
Arthur J. Gallagher & Co
AJG
$59.9B
| $472M | 0.1% |
1,524,561
-260,248
| -15% | -$78.5M |
2013 Q2
49 quarters
|
|
178
Public Storage
PSA
$53.8B
| $468M | 0.1% |
1,620,272
-305,694
| -16% | -$87.7M |
2013 Q2
49 quarters
|
|
179
Sempra
SRE
$52.6B
| $465M | 0.1% |
5,172,604
-937,306
| -15% | -$75.9M |
2013 Q2
49 quarters
|
|
180
Monster Beverage
MNST
$85.3B
| $465M | 0.1% |
13,815,900
-3,004,214
| -18% | -$93.8M |
2013 Q2
49 quarters
|
|
181
Aon
AON
$58.4B
| $465M | 0.1% |
1,303,846
-239,123
| -15% | -$86.5M |
2013 Q2
49 quarters
|
|
182
Ferguson
FERG
$42.2B
| $465M | 0.1% |
2,069,868
-413,213
| -17% | -$93.6M |
2022 Q4
11 quarters
|
|
183
Cencora
COR
$61.5B
| $461M | 0.1% |
1,475,859
+1,241,186
| +529% | +$365M |
2023 Q1
10 quarters
|
|
184
Veeva Systems
VEEV
$47B
| $458M | 0.1% |
1,538,996
-371,571
| -19% | -$105M |
2014 Q3
44 quarters
|
|
185
Atlassian
TEAM
$52B
| $458M | 0.1% |
2,867,886
+451,706
| +19% | +$81.7M |
2023 Q1
10 quarters
|
|
186
Northrop Grumman
NOC
$68.6B
| $457M | 0.1% |
749,562
-7,636
| -1% | -$4.33M |
2013 Q2
49 quarters
|
|
187
Consolidated Edison
ED
$39.1B
| $454M | 0.1% |
4,516,607
-839,234
| -16% | -$84.2M |
2013 Q2
49 quarters
|
|
188
United Rentals
URI
$66.1B
| $449M | 0.1% |
470,655
-130,486
| -22% | -$116M |
2013 Q2
49 quarters
|
|
189
Eversource Energy
ES
$24.7B
| $437M | 0.09% |
6,142,745
-432,992
| -7% | -$28.4M |
2013 Q2
49 quarters
|
|
190
Edwards Lifesciences
EW
$48.1B
| $434M | 0.09% |
5,584,646
+4,108,270
| +278% | +$321M |
2013 Q2
49 quarters
|
|
191
KKR & Co
KKR
$82.1B
| $432M | 0.09% |
3,326,913
-980,946
| -23% | -$139M |
2017 Q4
31 quarters
|
|
192
CBRE Group
CBRE
$37.6B
| $432M | 0.09% |
2,743,393
-593,062
| -18% | -$91.7M |
2013 Q2
49 quarters
|
|
193
Crown Castle
CCI
$33.3B
| $431M | 0.09% |
4,471,120
+3,824,778
| +592% | +$387M |
2013 Q2
49 quarters
|
|
194
Kimberly-Clark
KMB
$32.5B
| $431M | 0.09% |
3,469,508
-356,574
| -9% | -$46.1M |
2013 Q2
49 quarters
|
|
195
Ingersoll Rand
IR
$30.6B
| $430M | 0.09% |
5,203,303
-137,217
| -3% | -$11.2M |
2017 Q3
32 quarters
|
|
196
Truist Financial
TFC
$56.1B
| $427M | 0.09% |
9,330,295
-3,010,240
| -24% | -$136M |
2013 Q2
49 quarters
|
|
197
Quanta Services
PWR
$105B
| $421M | 0.09% |
1,016,074
-297,813
| -23% | -$116M |
2013 Q2
49 quarters
|
|
198
Baker Hughes
BKR
$56.4B
| $421M | 0.09% |
8,640,926
-1,999,157
| -19% | -$88.2M |
2017 Q3
32 quarters
|
|
|
AXON
199
Axon Enterprise
AXON
$34.1B
| $419M | 0.09% |
584,142
-131,927
| -18% | -$100M |
2013 Q2
49 quarters
|
|
200
Regeneron Pharmaceuticals
REGN
$76.6B
| $418M | 0.09% |
744,173
-116,268
| -14% | -$65.7M |
2013 Q2
49 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.